For integration with the six pan-cancer immune subtypes [18], we found that approximately 97% of CC patients belong to the wound healing (C1) (26.3%) or IFN-γ-dominant (C2) (70.6%) subtypes, while other subtypes accounted for only 3% of CC samples (Fig. 1b) [30]. This evidence concerns the gene IFNG and cancer.